Daré Bioscience to Showcase Life-Saving Solutions at Maxim Group’s Virtual Healthcare Conference

Daré Bioscience, Inc. (NASDAQ: DARE) is pleased to announce that Sabrina Martucci Johnson, President and CEO of the pioneering women’s health leader, will be an esteemed guest speaker at the Maxim Group LLC hosted Healthcare Virtual Conference this June 20 – 22, 2023. The exciting event, hosted by M-Vest, will be the perfect opportunity for Johnson to share her vast knowledge and expertise in the biotech industry with global leaders and attendees.

About Daré Bioscience

Daré Bioscience is revolutionizing the way we care for women by jumping into the biopharmaceutical arena. Our mission is to develop and provide innovative treatments to improve the health and wellbeing of women, primarily in the areas of contraception, vaginal health, reproductive health, menopause, sexual health and fertility. By doing so, we aim to create better treatment options for women everywhere and expand access to high-quality healthcare.

Daré Biopharma is revolutionizing women’s health with its FDA-approved product XACIATO™ (clindamycin phosphate) vaginal gel, 2%, and its diverse portfolio of potential first-in-category candidates in clinical development. XACIATO, under a global license agreement with Organon, is indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older.

Future product candidates include Ovaprene®, a novel, hormone-free monthly intravaginal contraceptive, Sildenafil Cream, 3.6%, a cream formulation of sildenafil to treat female sexual arousal disorder, and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for menopausal hormone therapy.

At Daré, we are dedicated to meeting the evolving needs of women, delivering innovative and differentiated therapies for their unique health conditions. Visit www.darebioscience.com to learn more about how we can help you.

Stay informed about Daré’s finances, products, product candidates, clinical trials and other key matters! Follow Daré’s investor relations website and social media accounts, including @SabrinaDareCEO and @DareBioscience, for the latest information and updates. As a leading innovator in the field, Daré is committed to providing its stakeholders, investors, media outlets, and followers with the essential material information necessary to make informed decisions. Keep up with the latest news and don’t miss any updates on the company!

Leave a Comment